Home/Vitro Biopharma/Thomas Ohrt
TO

Thomas Ohrt

Chief Financial Officer

Vitro Biopharma

Vitro Biopharma Pipeline

DrugIndicationPhase
AlloRx Stem Cell therapyAutoimmune/Inflammatory DisordersNot Disclosed